Turn Therapeutics Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 24 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|
| – | – | +0.4% | +179.6% | +53.3% | -9.0% | |
| – | – | -2.9% | +57.7% | +120.4% | -8.9% | |
| – | – | -2.6% | +63.4% | +121.0% | -8.3% | |
| – | – | -2.6% | +63.4% | +121.0% | -8.3% | |
| – | – | +9.2% | +1.9% | -0.2% | -0.9% | |
| – | – | +48.4% | +97.1% | +67.6% | +29.9% | |
| – | – | +117.7% | +160.0% | -14.5% | +70.8% | |
| – | – | +3.3% | +3.3% | +3.2% | +3.2% | |
| – | – | – | +29.3% | -20.9% | +12.5% | |
| – | – | – | – | – | +2.1% | |
| – | – | -68.6% | +741.8% | +30.5% | -88.8% | |
| – | – | – | – | – | – | |
| – | +3.1% | +103.9% | +5.1% | +0.1% | +1.1% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.